TAS-102 mechanism of action and potential toxicity in advanced CRC
Eric Van Cutsem, MD of University of Leuven discusses the TAS-102 mechanism of action and potential toxicity in advanced CRC
Author: ASCOGI2016
Added: 01/29/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Toxicology